Rossi Wants To Win Moto2 & 3
MCN Motorcycle News|February 15,2017

The GOAT aims to take MotoGP title and hopes his VR46 Academy stars can claim crowns in smaller classes.

Simon Patterson

Valentino Rossi and his army of VR46 Academy protégés have set themselves the ambitious target of securing victory in all three classes in 2017.

In Moto3, Rossi’s SKY-backed team of Andrea Migno and Nicolò Bulega have the potential to fight for the title while in Moto2 his VR46 Academy riders Lorenzo Baldassarri and Rossi’s own brother Luca Marini will be going all out for glory riding for the proven Forward Racing squad.

The 2017 season will also see Rossi’s own team expand into Moto2, with the same Team SKY set-up he runs in Moto3 now operating in Moto2 with fast Italians Francesco Bagnaia and Stefano Manzi.

Continue reading your story on the app

Continue reading your story in the magazine

RELATED STORIES

The Activists Are Back

Agitators such as Nelson Peltz and Elliott Management are going after noteworthy names now that stock prices are down

5 mins read
Bloomberg Businessweek US
February 13, 2023

THE TECH RESISTANCE MAKING OFFICE LIKE HELL

Advice on how to tackle ineptitude or strategic incompetence in the workplace

7 mins read
Bloomberg Businessweek US
February 13, 2023

CALL ME MAYBE?

When Zoom fatigue sets in, it's probably time to pick up the good ol’ telephone for a one-to-one Chat

3 mins read
Bloomberg Businessweek US
February 13, 2023

A Billionaire's Tough Strategy Goes Awry

Jorge Paulo Lemann set stiff cost-cutting goals. Did Americanas brass go too far to meet them?

6 mins read
Bloomberg Businessweek US
February 13, 2023

The Little Shop That Shook India

Nate Anderson’s Hindenburg Research makes money by making companies miserable

4 mins read
Bloomberg Businessweek US
February 13, 2023

A Rolling Recession Is the Best Kind

A series of sectoral downturns may help subdue inflation without significant job losses

4 mins read
Bloomberg Businessweek US
February 13, 2023

BED BATH & BEYOND HOPE

The near-bankrupt retailer was hit by Covid, but it has plenty of its own missteps to blame

7 mins read
Bloomberg Businessweek US
February 13, 2023

This Peanut Allergy Pill Is A Tough Nut to Crack

Nestlé spent $2.6 billion on Palforzia, but sales of the drug have been a disappointment, and the investment may be written down

5 mins read
Bloomberg Businessweek US
February 13, 2023

Selling Influence

Startup LTK helps creators find sponsorships and set up e-commerce operations

5 mins read
Bloomberg Businessweek US
February 13, 2023

Dark Skies for The Cloud

There are signs of strain for a business that Big Tech has seen as its next big profit center

3 mins read
Bloomberg Businessweek US
February 13, 2023